Immunotherapy for human renal cell carcinoma by adoptive transfer of autologous transforming growth factor beta-insensitive CD8+ T cells.
Wang L, Wen W, Yuan J, Helfand B, Li Y, Shi C, Tian F, Zheng J, Wang F, Chen L, et al. Clin Cancer Res. 2010 Jan 1; 16(1):164-73. Epub 2009 Dec 22.